{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:27:13Z","timestamp":1781839633412,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopaedics & Traumatology: Surgery & Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.otsr.2024.103984","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:49:55Z","timestamp":1725367795000},"page":"103984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Does the use of topical vancomycin during primary hip or knee arthroplasty protect from infections?"],"prefix":"10.1016","volume":"111","author":[{"given":"Fran\u00e7ois","family":"Laudet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dutronc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0190-9462","authenticated-orcid":false,"given":"Pierre","family":"Meynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Costes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.otsr.2024.103984_bib0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2106\/JBJS.M.00285","article-title":"Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021","volume":"96","author":"Kurtz","year":"2014","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1302\/0301-620X.95B1.29835","article-title":"Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis","volume":"95-B","author":"Jenkins","year":"2013","journal-title":"Bone Joint J"},{"key":"10.1016\/j.otsr.2024.103984_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2022.103463","article-title":"Total knee arthroplasty in France: male-driven rise in procedures in 2009-2019 and projections for 2050","volume":"109","author":"Le Stum","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0020","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.arth.2007.10.017","article-title":"Infection burden for hip and knee arthroplasty in the United States","volume":"23","author":"Kurtz","year":"2008","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0025","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.arth.2009.08.011","article-title":"Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review","volume":"25","author":"Urquhart","year":"2010","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2106\/JBJS.L.00211","article-title":"Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees","volume":"95","author":"Namba","year":"2013","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0035","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","article-title":"Proceedings of the international consensus on periprosthetic joint infection","volume":"95-B","author":"Parvizi","year":"2013","journal-title":"Bone Joint J"},{"key":"10.1016\/j.otsr.2024.103984_bib0040","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2106\/JBJS.L.00679","article-title":"Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors","volume":"95","author":"Zmistowski","year":"2013","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0045","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2106\/JBJS.N.01196","article-title":"Management of modifiable risk factors prior to primary hip and knee arthroplasty: a readmission risk assessment tool","volume":"97","author":"Boraiah","year":"2015","journal-title":"J Bone Joint Surg-Am Vol"},{"key":"10.1016\/j.otsr.2024.103984_bib0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2106\/00004623-199604000-00005","article-title":"Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections*","volume":"78","author":"Tsukayama","year":"1996","journal-title":"J Bone Jt Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the United States","volume":"27","author":"Kurtz","year":"2012","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0060","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berr\u00edos-Torres","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0065","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1016\/j.arth.2018.11.022","article-title":"Is operative time a predictor for post-operative infection in primary total knee arthroplasty?","volume":"34","author":"Anis","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1302\/0301-620X.79B4.0790590","article-title":"Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995","volume":"79","author":"Espehaug","year":"1997","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.otsr.2024.103984_bib0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17453670710015229","article-title":"Efficacy of antibiotic-impregnated cement in total hip replacement","volume":"79","author":"Parvizi","year":"2008","journal-title":"Acta Orthop"},{"key":"10.1016\/j.otsr.2024.103984_bib0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.otsr.2018.07.007","article-title":"Calcium Phosphate Cement loaded with 10% vancomycin delivering high early and late local antibiotic concentration in vitro","volume":"104","author":"Chen","year":"2018","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.wneu.2014.12.033","article-title":"The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence","volume":"83","author":"Bakhsheshian","year":"2015","journal-title":"World Neurosurg"},{"key":"10.1016\/j.otsr.2024.103984_bib0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/BRS.0000000000001371","article-title":"Intrawound vancomycin decreases the risk of surgical site infection after posterior spine surgery: a multicenter analysis","volume":"43","author":"Devin","year":"2018","journal-title":"Spine"},{"key":"10.1016\/j.otsr.2024.103984_bib0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/BRS.0000000000001710","article-title":"Is intraoperative local vancomycin powder the answer to surgical site infections in spine surgery?","volume":"42","author":"Hey","year":"2017","journal-title":"Spine"},{"key":"10.1016\/j.otsr.2024.103984_bib0100","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.otsr.2014.05.022","article-title":"Topical intrawound application of vancomycin powder in addition to intravenous administration of antibiotics: a meta-analysis on the deep infection after spinal surgeries","volume":"100","author":"Xiong","year":"2014","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2022.103512","article-title":"Evolution of antibiotic susceptibility profiles of staphylococci from osteoarticular infections: a 10-year retrospective study","volume":"109","author":"Duployez","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.otsr.2020.01.007","article-title":"Role of intra-wound powdered vancomycin in primary total knee arthroplasty","volume":"106","author":"Xu","year":"2020","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5371\/hp.2018.30.1.37","article-title":"Intrawound vancomycin powder in primary total hip arthroplasty increases rate of sterile wound complications","volume":"30","author":"Dial","year":"2018","journal-title":"Hip Pelvis"},{"key":"10.1016\/j.otsr.2024.103984_bib0120","first-page":"53","article-title":"Noncemented total knee arthroplasty with a local prophylactic anti-infection agent: a prospective series of 135 cases","author":"Assor","year":"2010","journal-title":"Can J Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.artd.2018.07.011","article-title":"Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection","volume":"4","author":"Patel","year":"2018","journal-title":"Arthroplasty Today"},{"key":"10.1016\/j.otsr.2024.103984_bib0130","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jcot.2017.08.007","article-title":"Do local antibiotics reduce periprosthetic joint infections? A retrospective review of 744 cases","volume":"9","author":"Winkler","year":"2018","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.otsr.2024.103984_bib0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arth.2020.07.064","article-title":"Topical vancomycin powder and dilute povidone-iodine lavage reduce the rate of early periprosthetic joint infection after primary total knee arthroplasty","volume":"36","author":"Buchalter","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69958-0","article-title":"Intraarticular vancomycin powder is effective in preventing infections following total hip and knee arthroplasty","volume":"10","author":"Matziolis","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.otsr.2024.103984_bib0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13018-021-02344-2","article-title":"Low post-arthroplasty infection rate is possible in developing countries: long-term experience of local vancomycin use in Iran","volume":"16","author":"Tahmasebi","year":"2021","journal-title":"J Orthop Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0150","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1007\/s00167-019-05498-z","article-title":"Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties","volume":"27","author":"Hanada","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.otsr.2024.103984_bib0155","first-page":"8","article-title":"Decreased incidence of periprosthetic joint infection in total hip arthroplasty with use of topical vancomycin","author":"Crawford","year":"2018","journal-title":"Reconstr Rev"},{"key":"10.1016\/j.otsr.2024.103984_bib0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jajs.2017.08.001","article-title":"Prophylactic intrawound application of vancomycin in total knee arthroplasty","volume":"4","author":"Khatri","year":"2017","journal-title":"J Arthrosc Joint Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0165","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00167-019-05778-8","article-title":"No effect of vancomycin powder to prevent infection in primary total knee arthroplasty: a retrospective review of 976 cases","volume":"28","author":"Yavuz","year":"2020","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.otsr.2024.103984_bib0170","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1302\/2046-3758.911.BJR-2020-0190.R2","article-title":"Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial","volume":"9","author":"Xu","year":"2020","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2020.09.006","article-title":"The application of topical vancomycin powder for the prevention of surgical site infections in primary total hip and knee arthroplasty: a meta-analysis","volume":"107","author":"Peng","year":"2021","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2024.103984_bib0180","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.arth.2019.03.071","article-title":"Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a call for a prospective randomized trial","volume":"34","author":"Heckmann","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0185","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.arth.2017.10.044","article-title":"Vancomycin povidone-iodine protocol improves survivorship of periprosthetic joint infection treated with irrigation and debridement","volume":"33","author":"Riesgo","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0190","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2015.7.FOCUS15258","article-title":"Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review","volume":"39","author":"Ghobrial","year":"2015","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.otsr.2024.103984_bib0195","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","article-title":"The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria","volume":"33","author":"Parvizi","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0200","first-page":"341","article-title":"La proth\u00e8se de hanche infect\u00e9e: le point de vue du m\u00e9decin","volume":"86","author":"Coiffier","year":"2019","journal-title":"Rev Rhum Monogr"},{"key":"10.1016\/j.otsr.2024.103984_bib0205","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2106\/00004623-200311000-00029","article-title":"Minimally invasive total hip arthroplasty. Development, early results, and a critical analysis. Presented at the Annual Meeting of the American Orthopaedic Association, Charleston, South Carolina, USA, June 14, 2003","volume":"85","author":"Berry","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.otsr.2024.103984_bib0210","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.arth.2023.01.040","article-title":"Is topical vancomycin an option? A randomized controlled trial to determine the safety of the topical use of vancomycin powder in preventing postoperative infections in total knee arthroplasty, as compared with standard postoperative antibiotics","volume":"38","author":"Abuzaiter","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0215","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.arth.2022.03.047","article-title":"Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a continued call for a prospective randomized trial","volume":"37","author":"Movassaghi","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0220","article-title":"Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial","volume":"156","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0225","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.arth.2020.02.060","article-title":"Vancomycin powder and dilute povidone-iodine lavage for infection prophylaxis in high-risk total joint arthroplasty","volume":"35","author":"Iorio","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0230","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1016\/j.arth.2020.12.036","article-title":"Does the organism profile of periprosthetic joint infections change with a topical vancomycin powder and dilute povidone-iodine lavage protocol?","volume":"36","author":"Buchalter","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.otsr.2024.103984_bib0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4184\/asj.2018.12.1.162","article-title":"Do dose-dependent microbial changes occur during spine surgery as a result of applying intrawound vancomycin powder? A systematic literature review","volume":"12","author":"Xie","year":"2018","journal-title":"Asian Spine J"},{"key":"10.1016\/j.otsr.2024.103984_bib0240","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4103\/ajns.AJNS_294_17","article-title":"Comparison between 1 g and 2 g of intrawound vancomycin powder application for prophylaxis in posterior instrumented thoracic or lumbosacral spine surgery: a preliminary report","volume":"14","author":"Kunakornsawat","year":"2019","journal-title":"Asian J Neurosurg"},{"key":"10.1016\/j.otsr.2024.103984_bib0245","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033369","article-title":"Intrawound low-dose vancomycin is superior to high-dose in controlling the risk of wound dehiscence in spine surgeries","volume":"102","author":"Sonbol","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.otsr.2024.103984_bib0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/microorganisms8050671","article-title":"Does intra-wound vancomycin powder affect the action of intra-articular tranexamic acid in total joint replacement?","volume":"8","author":"Koutalos","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.otsr.2024.103984_bib0255","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/CORR.0000000000001777","article-title":"Can topical vancomycin prevent periprosthetic joint infection in hip and knee arthroplasty? A systematic review","volume":"479","author":"Wong","year":"2021","journal-title":"Clin Orthop"},{"key":"10.1016\/j.otsr.2024.103984_bib0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90302-7","article-title":"The bactericidal effect of vancomycin is not altered by tranexamic acid, adrenalin, dexamethasone, or lidocaine in vitro","volume":"11","author":"Schwerdt","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.otsr.2024.103984_bib0265","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.arthro.2011.08.301","article-title":"A surgical technique using presoaked vancomycin hamstring grafts to decrease the risk of infection after anterior cruciate ligament reconstruction","volume":"28","author":"Vertullo","year":"2012","journal-title":"Arthrosc J Arthrosc Relat Surg"},{"key":"10.1016\/j.otsr.2024.103984_bib0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jisako.2021.12.006","article-title":"The role of vancomycin-soaking of the graft in anterior cruciate ligament reconstruction","volume":"7","author":"Rodriguez-Merchan","year":"2022","journal-title":"J ISAKOS"},{"key":"10.1016\/j.otsr.2024.103984_bib0275","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.arth.2015.10.015","article-title":"Serum and wound vancomycin levels after intrawound administration in primary total joint arthroplasty","volume":"32","author":"Johnson","year":"2017","journal-title":"J Arthroplasty"}],"container-title":["Orthopaedics & Traumatology: Surgery & Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877056824002652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877056824002652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:03:28Z","timestamp":1769947408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877056824002652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1877056824002652"],"URL":"https:\/\/doi.org\/10.1016\/j.otsr.2024.103984","relation":{},"ISSN":["1877-0568"],"issn-type":[{"value":"1877-0568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the use of topical vancomycin during primary hip or knee arthroplasty protect from infections?","name":"articletitle","label":"Article Title"},{"value":"Orthopaedics & Traumatology: Surgery & Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otsr.2024.103984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103984"}}